White v. ACell, Inc.

CourtDistrict Court, D. Maryland
DecidedSeptember 1, 2021
Docket1:20-cv-00173
StatusUnknown

This text of White v. ACell, Inc. (White v. ACell, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
White v. ACell, Inc., (D. Md. 2021).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF MARYLAND

TODD WHITE, *

Plaintiff, *

v. * Civil Action No. GLR-20-173

ACELL, INC., *

Defendant. * *** MEMORANDUM OPINION THIS MATTER is before the Court on Defendant ACell, Inc.’s (“ACell”) Motion for Summary Judgment (ECF No. 51). The Motion is ripe for disposition and no hearing is necessary. See Local Rule 105.6 (D.Md. 2021). For the reasons outlined below, the Court will grant in part and deny in part ACell’s Motion. I. BACKGROUND A. Factual Background On September 16, 2013, ACell hired Plaintiff Todd White, who is African American, as a sales representative. (Offer Letter at 1, ECF No. 51-33). In this role, he was responsible for selling medical devices produced by ACell, focusing his sales on surgical grafts and powders utilized by vascular, colorectal, plastic, and general surgeons. (Decl. Todd White [“White Decl.”] ¶ 3, ECF No. 56-17). In 2014, White began reporting to Area Manager Anthony Bonacorso, who in turn reported to Region Manager Mike Snyder. (Todd White Dep. [“White Dep.”] at 44:6–11, ECF Nos. 51-2, 56-13; Anthony Bonacorso Dep. [“Bonacorso Dep.”]1 at 190:19–20, ECF Nos. 51-21, 56-5).

1. Historical Sales Performance ACell has introduced evidence reflecting that during his time with the company, White consistently fell short of his sales targets. For example, one exhibit to ACell’s Motion is a spreadsheet containing White’s sales figures as compared to his goals for each period. The spreadsheet indicates that in 2014, White had $344,091 in sales, as compared to a budget2 of $696,870; in 2015, White had $620,467 in sales, as compared to a budget

of $681,710; in 2016, White had $673,373 in sales, as compared to a budget of $612,000; and in 2017, White had $652,906 in sales, as compared to a budget of $728,880. (White Sales Performance Spreadsheet [“Sales Spreadsheet”] at 3–7, ECF No. 51-11).3 White counters that his sales fell below his target goals because he was responsible for an unusually large sales territory. (White Decl. ¶ 4, ECF No. 56-17). Additionally,

White asserts that Bonacorso conceded that White was growing the business in that territory at a “decent” rate.4 White also notes that he was nominated for a prestigious

1 Although Bonacorso’s deposition was taken over the course of one day, it was produced in two volumes. ECF No. 51-21 contains excerpts from both volumes of Bonacorso’s deposition transcript, while ECF No. 56-5 only contains excerpts from Volume I. The Court will cite to excerpts from Volume I of Bonacorso’s deposition as “Bonacorso Dep.” and cite to excerpts from Volume II of the deposition as “Bonacorso Dep. Vol. II.” 2 ACell refers to its representatives’ sales targets as “budgets.” 3 When referencing exhibits without clear pagination, such as this one, citations to page numbers refer to the pagination assigned by the Court’s Case Management/Electronic Case Files (“CM/ECF”) system. 4 In an apparent clerical mistake, White cites Snyder’s deposition testimony, not Bonacorso’s, in support of this assertion, and the referenced pages of Snyder’s testimony company award in 2014, which belies the argument that his performance was below par that year. (Spievack Award Announcement at 3, ECF No. 56-29). White also points to a

series of text messages and other communications from Bonacorso between June 2016 and January 2018 in which Bonacorso repeatedly praises White. (See ECF Nos. 29–34). 2. Removal from Hospitals In March and November 2017, White was banned from selling ACell products in two health systems due to his alleged misconduct while on location at hospitals in those health systems. The first ban related to a January 2017 incident in which an ACell

customer, Henry Ford Health System (“Henry Ford”), accused White of throwing his shoe at a hospital employee at the Henry Ford location in Wyandotte, Michigan. (See Mar. 29, 2017 Henry Ford Letter [“Ford Letter”] at 1, ECF No. 51-5). Sales representatives visiting the location are required to offer personal collateral, generally car keys or a driver’s license, in exchange for borrowing hospital scrubs for the duration of their visit. (White Dep. at

200:14–201:6). White states that he was not carrying his license and did not want to provide the keys to his new car, so instead he placed his shoes on the counter and offered them as collateral. (Id. at 201:8–203:11). The hospital representative took exception to this and voiced her displeasure. (Id. at 203:11–204:17). White asserts that the following day, the hospital’s surgical director called White

and told him that he would “never work another case in here ever again . . . . You threw a

do not relate to White’s sales efforts. (See Mem. Opp’n Def.’s Mot. Summ. J. [“Opp’n”] at 13, ECF No. 56-1; Mike Snyder Dep. [“Snyder Dep.”] at 114–15, ECF Nos. 51-20, 56- 4). shoe . . . . I want to talk to your manager.” (Id. at 204:21–206:18). Following the incident, White was “no longer welcome” in Henry Ford hospitals, (id. at 208:3–6), and Henry Ford

formalized the decision with a permanent ban on March 29, 2017, (Ford Letter at 1). Snyder testified that at the time, he credited White’s description of the incident, i.e., that the Henry Ford representative had overreacted to White’s reasonable behavior. (Snyder Dep. at 169:21–171:19). The incident preceding the second ban occurred on October 31, 2017. On that day, White was in the operating room at a Beaumont Health System (“Beaumont”) hospital in

Farmington Hills, Michigan (“Beaumont Farmington”), when a surgeon, Dr. David Fertel, began an argument with the hospital’s surgical director, Steven Witkowski, relating to the use of certain ACell products. (White Dep. at 247:1–248:12). During the argument, Fertel called on White to confirm that the ACell products involved in the disagreement were exempt from certain regulations that would have affected Fertel’s treatment of the patient.

(Id. at 248:19–249:12). White did so, and Fertel proceeded with the course of treatment, but Witkowski directed White to come and speak to him before he left. (Id. at 249:7–20). White testified that as he left, he called Bonacorso and informed him that they had “a major problem.” (Id. at 250:11–13). White then encountered Witkowski, who informed White that he wanted to talk to White’s manager. (Id. at 250:16–251:4). White provided

Witkowski with Bonacorso’s contact information. (Id.). Bonacorso testified that when White called him, he overheard White “screaming” at Witkowski. (Bonacorso Dep. at 139:14–140:7). However, Fertel testified that White was “professional” and “non- confrontational” in his interactions at the hospital that day. (David Fertel Decl. ¶ 5, ECF No. 56-39). Snyder and Bonacorso agreed that regardless of whether White was technically correct in supporting Fertel, he had handled the incident incorrectly by becoming involved.

(Bonacorso Dep. at 139:3–23; Snyder Dep. at 195:8–18, 198:6–13). Approximately one month later, Witkowski sent ACell a letter banning White from selling products at Beaumont’s Farmington location. (Nov. 28, 2017 Beaumont Letter at 1, ECF No. 56-40). Although the letter referred to only the Farmington location, White testified that he believed he had been banned from “the whole Beaumont system, not just Farmington.” (White Dep. at 264:7–9, 272:2–11). Snyder and Bonacorso shared this

understanding. (Snyder Dep. at 177:14–19; Bonacorso Dep. at 142:17–19). White speculates that Bonacorso persuaded Witkowski to ban White from the Beaumont system. (White Dep. at 262:14–21, 263:21–264:9). As a result of the two bans, ACell transferred White’s Henry Ford and Beaumont accounts to another sales representative. (May 15, 2017 Email Exchange at 2–3, ECF No. 51-6; 2017 Sales Totals Spreadsheet at 2, ECF No. 51-

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Merritt v. Old Dominion Freight Line, Inc.
601 F.3d 289 (Fourth Circuit, 2010)
Adickes v. S. H. Kress & Co.
398 U.S. 144 (Supreme Court, 1970)
McDonnell Douglas Corp. v. Green
411 U.S. 792 (Supreme Court, 1973)
Texas Department of Community Affairs v. Burdine
450 U.S. 248 (Supreme Court, 1981)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Ricci v. DeStefano
557 U.S. 557 (Supreme Court, 2009)
Coleman v. Maryland Court of Appeals
626 F.3d 187 (Fourth Circuit, 2010)
Paul Carter v. William L. Ball, III
33 F.3d 450 (Fourth Circuit, 1994)
Kate Frazier v. Fairhaven School Committee
276 F.3d 52 (First Circuit, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
White v. ACell, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/white-v-acell-inc-mdd-2021.